Publication | Open Access
Cell-based analysis of CAD variants identifies individuals likely to benefit from uridine therapy
25
Citations
18
References
2020
Year
We designed a cell-based assay to test the pathogenicity of CAD variants, identifying 11 CAD-deficient individuals who could benefit from uridine therapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1